The potential of cardiac magnetic resonance to improve cardiovascular care and patient
management is considerable. Myocardial T1-rho (T1ρ) mapping, in particular, has emerged …

Myocardial fibrosis (MF) is defined as excessive production and deposition of extra-cellular
matrix (ECM) proteins that result in pathologic myocardial remodeling. Three types of MF …

Background There is limited evidence on the risk stratification of cardiovascular outcomes in
patients with Fabry disease (FD). Objectives This study sought to classify FD patients into …

Background Myocardial T1‐rho (T1ρ) mapping is a promising method for identifying and
quantifying myocardial injuries without contrast agents, but its clinical use is hindered by the …

Abstract Cardiac Magnetic Resonance Fingerprinting (cMRF) has been demonstrated to
enable robust and accurate T1 and T2 mapping for the detection of myocardial fibrosis and …

Background In cardiovascular magnetic resonance imaging parametric T1 mapping lacks
universally valid reference values. This limits its extensive use in the clinical routine. The aim …

Tissue characterisation using T1 mapping has become an established magnetic resonance
imaging (MRI) technique to detect myocardial diseases. This retrospective study aimed to …

Cardiometabolic disease refers to the spectrum of chronic conditions that include diabetes,
hypertension, atheromatosis, non-alcoholic fatty liver disease, and their long-term impact on …

Purpose To develop and validate a highly efficient motion compensated free‐breathing
isotropic resolution 3D whole‐heart joint T1/T2 mapping sequence with anatomical water/fat …

Background To facilitate the clinical use of cardiac T1ρ, it is important to understand the
impact of age and sex on T1ρ values of the myocardium. Purpose To investigate the impact …